HL7 BE Laboratory Result WG Implementation Guide (work in progress)
0.0.7 - CI Build

HL7 BE Laboratory Result WG Implementation Guide (work in progress), published by HL7 Belgium. This is not an authorized publication; it is the continuous build for version 0.0.7). This version is based on the current content of https://github.com/hl7-be/hl7-be-fhir-laboratory-report/ and changes regularly. See the Directory of published versions

: Structured Antibiogram in collection bundle - JSON Representation

Raw json | Download


{
  "resourceType" : "Bundle",
  "id" : "antibiogramAsBundleNN",
  "identifier" : {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:uuid:0c3151bd-1cbf-4d99-b04d-cd9187a4c6e0"
  },
  "type" : "collection",
  "entry" : [
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d34",
      "resource" : {
        "resourceType" : "DiagnosticReport",
        "id" : "diagnosticreport50",
        "meta" : {
          "versionId" : "1",
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-laboratory-report"
          ]
        },
        "language" : "en",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"diagnosticreport50\" Version \"1\"  (Language \"en\") </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-laboratory-report.html\">BeLaboratoryReport</a></p></div><p><b>identifier</b>: id: 11530231003.2015110413180000000</p><p><b>basedOn</b>: <a href=\"#ServiceRequest_servicerequest50\">See above (ServiceRequest/servicerequest50)</a></p><p><b>status</b>: final</p><p><b>category</b>: Laboratory <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v2-0074.html\">diagnosticServiceSectionId</a>#LAB; <a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v2-0074.html\">diagnosticServiceSectionId</a>#MB \"Microbiology\")</span></p><p><b>code</b>: Microbial susceptibility tests <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#18769-0 \"Microbial susceptibility tests Set\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-03 01:18:00+0100</p><p><b>issued</b>: Nov 4, 2015, 12:18:00 PM</p><p><b>performer</b>: <a href=\"#Organization_organization10\">See above (Organization/organization10)</a></p><p><b>resultsInterpreter</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>specimen</b>: <a href=\"#Specimen_specimen50\">See above (Specimen/specimen50)</a></p><p><b>result</b>: </p><ul><li><a href=\"#Observation_org51\">See above (Observation/org51)</a></li><li><a href=\"#Observation_org52\">See above (Observation/org52)</a></li><li><a href=\"#Observation_dr50-mrsa\">See above (Observation/dr50-mrsa)</a></li><li><a href=\"#Observation_dr50-mrgn\">See above (Observation/dr50-mrgn)</a></li></ul><p><b>conclusion</b>: This is our conclusion</p></div>"
        },
        "identifier" : [
          {
            "system" : "https://www.ehealth.fgov.be/standards/fhir/NamingSystem/be-ns-lab-report-diagnostic-report-id",
            "value" : "11530231003.2015110413180000000"
          }
        ],
        "basedOn" : [
          {
            "reference" : "ServiceRequest/servicerequest50"
          }
        ],
        "status" : "final",
        "category" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
                "code" : "LAB",
                "display" : "Laboratory"
              },
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v2-0074",
                "code" : "MB",
                "display" : "Microbiology"
              }
            ]
          }
        ],
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "18769-0",
              "display" : "Microbial susceptibility tests Set"
            }
          ],
          "text" : "Microbial susceptibility tests"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-03T13:18:00+01:00",
        "issued" : "2015-11-04T13:18:00+01:00",
        "performer" : [
          {
            "reference" : "Organization/organization10"
          }
        ],
        "resultsInterpreter" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "specimen" : [
          {
            "reference" : "Specimen/specimen50"
          }
        ],
        "result" : [
          {
            "reference" : "Observation/org51"
          },
          {
            "reference" : "Observation/org52"
          },
          {
            "reference" : "Observation/dr50-mrsa"
          },
          {
            "reference" : "Observation/dr50-mrgn"
          }
        ],
        "conclusion" : "This is our conclusion"
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d36",
      "resource" : {
        "resourceType" : "Specimen",
        "id" : "specimen50",
        "meta" : {
          "versionId" : "1",
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-specimen-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"specimen50\" Version \"1\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-specimen-laboratory.html\">BeSpecimenLaboratory</a></p></div><p><b>identifier</b>: id: 1</p><p><b>status</b>: available</p><p><b>type</b>: A string can be added to nuance or explain. <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#258529004 \"Throat swab\")</span></p><p><b>receivedTime</b>: 2015-11-04</p><p><b>note</b>: Some extra relevant information concerning the specimen</p></div>"
        },
        "identifier" : [
          {
            "system" : "https://www.GTL-LABO.be/",
            "value" : "1"
          }
        ],
        "status" : "available",
        "type" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "258529004",
              "display" : "Throat swab"
            }
          ],
          "text" : "A string can be added to nuance or explain."
        },
        "receivedTime" : "2015-11-04",
        "note" : [
          {
            "text" : "Some extra relevant information concerning the specimen"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d37",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Bacteria identified in Mouth by Culture <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#73960-7)</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>value</b>: Morganella morganii <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#243301005)</span></p><p><b>specimen</b>: <a href=\"#Specimen_specimen50\">See above (Specimen/specimen50)</a></p><p><b>hasMember</b>: </p><ul><li><a href=\"#Observation_org51-ampicilin\">See above (Observation/org51-ampicilin)</a></li><li><a href=\"#Observation_org51-trimethoprim-sulfamethoxazole\">See above (Observation/org51-trimethoprim-sulfamethoxazole)</a></li><li><a href=\"#Observation_org51-nitrofurantoin\">See above (Observation/org51-nitrofurantoin)</a></li><li><a href=\"#Observation_org51-cefuroxime\">See above (Observation/org51-cefuroxime)</a></li><li><a href=\"#Observation_org51-gentamicin\">See above (Observation/org51-gentamicin)</a></li><li><a href=\"#Observation_org51-colistin\">See above (Observation/org51-colistin)</a></li><li><a href=\"#Observation_org51-temocillin\">See above (Observation/org51-temocillin)</a></li><li><a href=\"#Observation_org51-fosfomycin\">See above (Observation/org51-fosfomycin)</a></li><li><a href=\"#Observation_org51-levofloxacin\">See above (Observation/org51-levofloxacin)</a></li><li><a href=\"#Observation_org51-ofloxacin\">See above (Observation/org51-ofloxacin)</a></li><li><a href=\"#Observation_org51-amoxicillin-clavulanate\">See above (Observation/org51-amoxicillin-clavulanate)</a></li><li><a href=\"#Observation_org51-amikacin\">See above (Observation/org51-amikacin)</a></li><li><a href=\"#Observation_org51-piperacillin-tazobactam\">See above (Observation/org51-piperacillin-tazobactam)</a></li><li><a href=\"#Observation_org51-ceftriaxone\">See above (Observation/org51-ceftriaxone)</a></li><li><a href=\"#Observation_org51-cefotaxime\">See above (Observation/org51-cefotaxime)</a></li><li><a href=\"#Observation_org51-ceftazidime\">See above (Observation/org51-ceftazidime)</a></li><li><a href=\"#Observation_org51-meropenem\">See above (Observation/org51-meropenem)</a></li></ul></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "73960-7",
              "display" : "Bacteria identified in Mouth by Culture"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueCodeableConcept" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "243301005",
              "display" : "Morganella morganii"
            }
          ]
        },
        "specimen" : {
          "reference" : "Specimen/specimen50"
        },
        "hasMember" : [
          {
            "reference" : "Observation/org51-ampicilin"
          },
          {
            "reference" : "Observation/org51-trimethoprim-sulfamethoxazole"
          },
          {
            "reference" : "Observation/org51-nitrofurantoin"
          },
          {
            "reference" : "Observation/org51-cefuroxime"
          },
          {
            "reference" : "Observation/org51-gentamicin"
          },
          {
            "reference" : "Observation/org51-colistin"
          },
          {
            "reference" : "Observation/org51-temocillin"
          },
          {
            "reference" : "Observation/org51-fosfomycin"
          },
          {
            "reference" : "Observation/org51-levofloxacin"
          },
          {
            "reference" : "Observation/org51-ofloxacin"
          },
          {
            "reference" : "Observation/org51-amoxicillin-clavulanate"
          },
          {
            "reference" : "Observation/org51-amikacin"
          },
          {
            "reference" : "Observation/org51-piperacillin-tazobactam"
          },
          {
            "reference" : "Observation/org51-ceftriaxone"
          },
          {
            "reference" : "Observation/org51-cefotaxime"
          },
          {
            "reference" : "Observation/org51-ceftazidime"
          },
          {
            "reference" : "Observation/org51-meropenem"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d38",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ampicilin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-ampicilin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ampicillin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#29-9 \"Ampicillin [Susceptibility] by Disk diffusion (KB)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Resistant <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#R)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "29-9",
              "display" : "Ampicillin [Susceptibility] by Disk diffusion (KB)"
            }
          ],
          "text" : "Ampicillin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d39",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-trimethoprim-sulfamethoxazole",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-trimethoprim-sulfamethoxazole\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Trimethoprim+Sulfamethoxazole <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#516-5 \"Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "516-5",
              "display" : "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Trimethoprim+Sulfamethoxazole"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d40",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-nitrofurantoin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-nitrofurantoin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Nitrofurantoin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#363-2 \"Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Resistant <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#R)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "363-2",
              "display" : "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Nitrofurantoin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d41",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-cefuroxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-cefuroxime\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Cefuroxime <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#51774-8 \"Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Resistant <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#R)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "51774-8",
              "display" : "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefuroxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d42",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-gentamicin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-gentamicin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Gentamicin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#267-5 \"Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "267-5",
              "display" : "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Gentamicin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d43",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-colistin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-colistin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Colistin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#205-5 \"Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Resistant <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#R)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "205-5",
              "display" : "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Colistin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d44",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-temocillin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-temocillin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Temocillin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#492-9 \"Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "492-9",
              "display" : "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Temocillin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d45",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-fosfomycin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-fosfomycin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Fosfomycin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#25653-7 \"Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "25653-7",
              "display" : "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Fosfomycin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d46",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-levofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-levofloxacin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Levofloxacin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#20396-8 \"levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20396-8",
              "display" : "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Levofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d47",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-ofloxacin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ofloxacin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#375-6 \"Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "375-6",
              "display" : "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d48",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-amoxicillin-clavulanate",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-amoxicillin-clavulanate\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Amoxicillin+Clavulanate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#20-8 \"Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Resistant <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#R)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20-8",
              "display" : "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amoxicillin+Clavulanate"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "R",
                "display" : "Resistant"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d49",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-amikacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-amikacin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Amikacin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#12-5 \"Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "12-5",
              "display" : "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amikacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d50",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-piperacillin-tazobactam",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-piperacillin-tazobactam\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Piperacillin+Tazobactam <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#412-7 \"Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "412-7",
              "display" : "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Piperacillin+Tazobactam"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d51",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ceftriaxone",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-ceftriaxone\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ceftriaxone <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#141-2 \"cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "141-2",
              "display" : "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftriaxone"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d52",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-cefotaxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-cefotaxime\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Cefotaxime <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#108-1 \"Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "108-1",
              "display" : "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefotaxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d53",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-ceftazidime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-ceftazidime\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ceftazidime <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#133-9 \"cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "133-9",
              "display" : "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftazidime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d54",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org51-meropenem",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org51-meropenem\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Meropenem <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#6652-2 \"Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "6652-2",
              "display" : "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Meropenem"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d55",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Bacteria identified in Mouth by Culture <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#73960-7)</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>value</b>: Escherichia coli <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#112283007)</span></p><p><b>specimen</b>: <a href=\"#Specimen_specimen50\">See above (Specimen/specimen50)</a></p><p><b>hasMember</b>: </p><ul><li><a href=\"#Observation_org52-ampicilin\">See above (Observation/org52-ampicilin)</a></li><li><a href=\"#Observation_org52-trimethoprim-sulfamethoxazole\">See above (Observation/org52-trimethoprim-sulfamethoxazole)</a></li><li><a href=\"#Observation_org52-nitrofurantoin\">See above (Observation/org52-nitrofurantoin)</a></li><li><a href=\"#Observation_org52-cefuroxime\">See above (Observation/org52-cefuroxime)</a></li><li><a href=\"#Observation_org52-gentamicin\">See above (Observation/org52-gentamicin)</a></li><li><a href=\"#Observation_org52-colistin\">See above (Observation/org52-colistin)</a></li><li><a href=\"#Observation_org52-temocillin\">See above (Observation/org52-temocillin)</a></li><li><a href=\"#Observation_org52-fosfomycin\">See above (Observation/org52-fosfomycin)</a></li><li><a href=\"#Observation_org52-levofloxacin\">See above (Observation/org52-levofloxacin)</a></li><li><a href=\"#Observation_org52-ofloxacin\">See above (Observation/org52-ofloxacin)</a></li><li><a href=\"#Observation_org52-amoxicillin-clavulanate\">See above (Observation/org52-amoxicillin-clavulanate)</a></li><li><a href=\"#Observation_org52-amikacin\">See above (Observation/org52-amikacin)</a></li><li><a href=\"#Observation_org52-piperacillin-tazobactam\">See above (Observation/org52-piperacillin-tazobactam)</a></li><li><a href=\"#Observation_org52-ceftriaxone\">See above (Observation/org52-ceftriaxone)</a></li><li><a href=\"#Observation_org52-cefotaxime\">See above (Observation/org52-cefotaxime)</a></li><li><a href=\"#Observation_org52-ceftazidime\">See above (Observation/org52-ceftazidime)</a></li><li><a href=\"#Observation_org52-meropenem\">See above (Observation/org52-meropenem)</a></li></ul></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "73960-7",
              "display" : "Bacteria identified in Mouth by Culture"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueCodeableConcept" : {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "112283007",
              "display" : "Escherichia coli"
            }
          ]
        },
        "specimen" : {
          "reference" : "Specimen/specimen50"
        },
        "hasMember" : [
          {
            "reference" : "Observation/org52-ampicilin"
          },
          {
            "reference" : "Observation/org52-trimethoprim-sulfamethoxazole"
          },
          {
            "reference" : "Observation/org52-nitrofurantoin"
          },
          {
            "reference" : "Observation/org52-cefuroxime"
          },
          {
            "reference" : "Observation/org52-gentamicin"
          },
          {
            "reference" : "Observation/org52-colistin"
          },
          {
            "reference" : "Observation/org52-temocillin"
          },
          {
            "reference" : "Observation/org52-fosfomycin"
          },
          {
            "reference" : "Observation/org52-levofloxacin"
          },
          {
            "reference" : "Observation/org52-ofloxacin"
          },
          {
            "reference" : "Observation/org52-amoxicillin-clavulanate"
          },
          {
            "reference" : "Observation/org52-amikacin"
          },
          {
            "reference" : "Observation/org52-piperacillin-tazobactam"
          },
          {
            "reference" : "Observation/org52-ceftriaxone"
          },
          {
            "reference" : "Observation/org52-cefotaxime"
          },
          {
            "reference" : "Observation/org52-ceftazidime"
          },
          {
            "reference" : "Observation/org52-meropenem"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae01-48abcadd8d56",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ampicilin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-ampicilin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ampicillin [Susceptibility] by Disk diffusion (KB) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#29-9)</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "29-9",
              "display" : "Ampicillin [Susceptibility] by Disk diffusion (KB)"
            }
          ]
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae02-48abcadd8d57",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-trimethoprim-sulfamethoxazole",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-trimethoprim-sulfamethoxazole\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Trimethoprim+Sulfamethoxazole <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#516-5 \"Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "516-5",
              "display" : "Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Trimethoprim+Sulfamethoxazole"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae03-48abcadd8d58",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-nitrofurantoin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-nitrofurantoin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Nitrofurantoin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#363-2 \"Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "363-2",
              "display" : "Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Nitrofurantoin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae04-48abcadd8d59",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-cefuroxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-cefuroxime\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Cefuroxime <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#51774-8 \"Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "51774-8",
              "display" : "Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefuroxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae05-48abcadd8d60",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-gentamicin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-gentamicin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Gentamicin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#267-5 \"Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "267-5",
              "display" : "Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Gentamicin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae06-48abcadd8d61",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-colistin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-colistin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Colistin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#205-5 \"Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "205-5",
              "display" : "Colistin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Colistin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae07-48abcadd8d62",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-temocillin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-temocillin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Temocillin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#492-9 \"Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "492-9",
              "display" : "Temocillin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Temocillin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae08-48abcadd8d63",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-fosfomycin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-fosfomycin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Fosfomycin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#25653-7 \"Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "25653-7",
              "display" : "Fosfomycin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Fosfomycin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d64",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-levofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-levofloxacin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Levofloxacin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#20396-8 \"levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20396-8",
              "display" : "levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Levofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d65",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ofloxacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-ofloxacin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ofloxacin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#375-6 \"Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "375-6",
              "display" : "Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ofloxacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d66",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-amoxicillin-clavulanate",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-amoxicillin-clavulanate\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Amoxicillin+Clavulanate <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#20-8 \"Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "20-8",
              "display" : "Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amoxicillin+Clavulanate"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d67",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-amikacin",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-amikacin\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Amikacin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#12-5 \"Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "12-5",
              "display" : "Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Amikacin"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d68",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-piperacillin-tazobactam",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-piperacillin-tazobactam\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Piperacillin+Tazobactam <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#412-7 \"Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "412-7",
              "display" : "Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Piperacillin+Tazobactam"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d69",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ceftriaxone",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-ceftriaxone\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ceftriaxone <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#141-2 \"cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "141-2",
              "display" : "cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftriaxone"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d70",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-cefotaxime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-cefotaxime\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Cefotaxime <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#108-1 \"Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "108-1",
              "display" : "Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Cefotaxime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd8d71",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-ceftazidime",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-ceftazidime\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Ceftazidime <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#133-9 \"cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "133-9",
              "display" : "cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Ceftazidime"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d72",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "org52-meropenem",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"org52-meropenem\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: Meropenem <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#6652-2 \"Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>interpretation</b>: Susceptible <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/3.1.0/CodeSystem-v3-ObservationInterpretation.html\">ObservationInterpretation</a>#S)</span></p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "6652-2",
              "display" : "Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC)"
            }
          ],
          "text" : "Meropenem"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "interpretation" : [
          {
            "coding" : [
              {
                "system" : "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation",
                "code" : "S",
                "display" : "Susceptible"
              }
            ]
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d80",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "dr50-mrsa",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"dr50-mrsa\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: MRSA <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#35492-8 \"Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>value</b>: negative</p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "35492-8",
              "display" : "Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] in Unspecified specimen by NAA with probe detection"
            }
          ],
          "text" : "MRSA"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueString" : "negative"
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae09-48abcadd9d81",
      "resource" : {
        "resourceType" : "Observation",
        "id" : "dr50-mrgn",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-observation-laboratory"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"dr50-mrgn\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-be-observation-laboratory.html\">BeObservationLaboratory</a></p></div><p><b>status</b>: final</p><p><b>code</b>: MRGN <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://loinc.org/\">LOINC</a>#78702-8 \"Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture\")</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>effective</b>: 2015-11-04 09:16:00-0500</p><p><b>issued</b>: Nov 4, 2015, 2:16:00 PM</p><p><b>performer</b>: <a href=\"#Practitioner_practitioner11\">See above (Practitioner/practitioner11)</a></p><p><b>value</b>: negative</p></div>"
        },
        "status" : "final",
        "code" : {
          "coding" : [
            {
              "system" : "http://loinc.org",
              "code" : "78702-8",
              "display" : "Multiple drug resistant gram negative organism [Identifier] in Unspecified specimen by Culture"
            }
          ],
          "text" : "MRGN"
        },
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "effectiveDateTime" : "2015-11-04T09:16:00-05:00",
        "issued" : "2015-11-04T09:16:00-05:00",
        "performer" : [
          {
            "reference" : "Practitioner/practitioner11"
          }
        ],
        "valueString" : "negative"
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d72",
      "resource" : {
        "resourceType" : "Organization",
        "id" : "organization10",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-organization"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"organization10\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=ehealthplatform.be.r4.federalprofiles@1.2.2&amp;canonical=https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-organization\">BeOrganization</a></p></div><p><b>identifier</b>: Medical License number: 81165343998 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Independent laboratory <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://simplifier.net/resolve?scope=ehealthplatform.be.r4.federalprofiles@1.2.2&amp;canonical=https://www.ehealth.fgov.be/standards/fhir/CodeSystem/cd-hcparty\">HCParty</a>#orglaboratory)</span></p><p><b>name</b>: GTL - General Testing Laboratory</p><p><b>telecom</b>: ph: 322675199(WORK)</p><p><b>address</b>: Vulcansstraat 120, 1000 Brussel(WORK)</p></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "type" : {
              "coding" : [
                {
                  "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
                  "code" : "MD",
                  "display" : "Medical License number"
                }
              ]
            },
            "system" : "https://www.ehealth.fgov.be/standards/fhir/NamingSystem/nihdi",
            "value" : "81165343998"
          }
        ],
        "active" : true,
        "type" : [
          {
            "coding" : [
              {
                "system" : "https://www.ehealth.fgov.be/standards/fhir/CodeSystem/cd-hcparty",
                "code" : "orglaboratory"
              }
            ]
          }
        ],
        "name" : "GTL - General Testing Laboratory",
        "telecom" : [
          {
            "system" : "phone",
            "value" : "322675199",
            "use" : "work"
          }
        ],
        "address" : [
          {
            "extension" : [
              {
                "url" : "http://hl7.org/fhir/StructureDefinition/language",
                "valueCode" : "nl"
              }
            ],
            "use" : "work",
            "type" : "both",
            "text" : "Vulcansstraat 120, 1000 Brussel",
            "line" : [
              "Vulcansstraat 120"
            ],
            "_line" : [
              {
                "extension" : [
                  {
                    "url" : "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-streetName",
                    "valueString" : "Vulcansstraat"
                  },
                  {
                    "url" : "http://hl7.org/fhir/StructureDefinition/iso21090-ADXP-houseNumber",
                    "valueString" : "120"
                  }
                ]
              }
            ],
            "city" : "Brussel",
            "postalCode" : "1000",
            "country" : "BE"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d73",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "practitioner11",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-practitioner"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"practitioner11\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=ehealthplatform.be.r4.federalprofiles@1.2.2&amp;canonical=https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-practitioner\">BePractitioner</a></p></div><p><b>identifier</b>: id: 554488997 (OFFICIAL)</p><p><b>name</b>: Nicolas Davoust (OFFICIAL)</p><p><b>telecom</b>: <a href=\"mailto:nicolas.davoust@gtl.be\">nicolas.davoust@gtl.be</a>, ph: 022675198(WORK), fax: 022675209(WORK)</p></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.ehealth.fgov.be/standards/fhir/NamingSystem/nihdi",
            "value" : "554488997"
          }
        ],
        "name" : [
          {
            "use" : "official",
            "family" : "Davoust",
            "given" : [
              "Nicolas"
            ]
          }
        ],
        "telecom" : [
          {
            "system" : "email",
            "value" : "nicolas.davoust@gtl.be",
            "use" : "work"
          },
          {
            "system" : "phone",
            "value" : "022675198",
            "use" : "work"
          },
          {
            "system" : "fax",
            "value" : "022675209",
            "use" : "work"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d74",
      "resource" : {
        "resourceType" : "Patient",
        "id" : "patient1",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-patient"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"patient1\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=ehealthplatform.be.r4.federalprofiles@1.2.2&amp;canonical=https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-patient\">BePatient</a></p></div><p><b>identifier</b>: id: 79121137740 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>name</b>: Josephine Nessa La Paradisio </p><p><b>telecom</b>: <a href=\"mailto:nessa.laparadisio@belgium.be\">nessa.laparadisio@belgium.be</a>, <a href=\"tel:+322476792979\">+322476792979</a>, <a href=\"tel:+3226718655\">+3226718655</a>, <a href=\"tel:+322476799\">+322476799</a></p><p><b>gender</b>: female</p><p><b>birthDate</b>: 1979-12-11</p><p><b>address</b>: Sloordelle 42, 1160 Oudergem(HOME)</p></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.ehealth.fgov.be/standards/fhir/NamingSystem/ssin",
            "value" : "79121137740"
          }
        ],
        "active" : true,
        "name" : [
          {
            "family" : "La Paradisio",
            "given" : [
              "Josephine",
              "Nessa"
            ]
          }
        ],
        "telecom" : [
          {
            "system" : "email",
            "value" : "nessa.laparadisio@belgium.be"
          },
          {
            "system" : "phone",
            "value" : "+322476792979",
            "use" : "mobile"
          },
          {
            "system" : "phone",
            "value" : "+3226718655",
            "use" : "home"
          },
          {
            "system" : "phone",
            "value" : "+322476799",
            "use" : "work"
          }
        ],
        "gender" : "female",
        "birthDate" : "1979-12-11",
        "_birthDate" : {
          "extension" : [
            {
              "url" : "http://hl7.org/fhir/StructureDefinition/patient-birthTime",
              "valueDateTime" : "1979-12-11T13:28:17-05:00"
            }
          ]
        },
        "address" : [
          {
            "use" : "home",
            "type" : "both",
            "text" : "Sloordelle 42, 1160 Oudergem",
            "line" : [
              "Sloordelle 42"
            ],
            "city" : "Oudergem",
            "postalCode" : "1160",
            "country" : "BE"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d75",
      "resource" : {
        "resourceType" : "ServiceRequest",
        "id" : "servicerequest50",
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"servicerequest50\" </p></div><p><b>identifier</b>: id: 12334546</p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>category</b>: Laboratory procedure <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#108252007)</span></p><p><b>subject</b>: <a href=\"#Patient_patient1\">See above (Patient/patient1)</a></p><p><b>authoredOn</b>: 2015-11-01 02:41:00+0100</p><p><b>requester</b>: <a href=\"#Practitioner_practitioner1\">See above (Practitioner/practitioner1)</a></p><p><b>specimen</b>: <a href=\"#Specimen_specimen50\">See above (Specimen/specimen50)</a></p></div>"
        },
        "identifier" : [
          {
            "system" : "https://www.GTL-LABO.be/orderingsystem",
            "value" : "12334546"
          }
        ],
        "status" : "active",
        "intent" : "order",
        "category" : [
          {
            "coding" : [
              {
                "system" : "http://snomed.info/sct",
                "code" : "108252007",
                "display" : "Laboratory procedure"
              }
            ]
          }
        ],
        "subject" : {
          "reference" : "Patient/patient1"
        },
        "authoredOn" : "2015-11-01T14:41:00+01:00",
        "requester" : {
          "reference" : "Practitioner/practitioner1"
        },
        "specimen" : [
          {
            "reference" : "Specimen/specimen50"
          }
        ]
      }
    },
    {
      "fullUrl" : "urn:uuid:7c16c9c0-c471-4098-ae18-48abcadd8d76",
      "resource" : {
        "resourceType" : "Practitioner",
        "id" : "practitioner1",
        "meta" : {
          "profile" : [
            "https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-practitioner"
          ]
        },
        "text" : {
          "status" : "generated",
          "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource \"practitioner1\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"https://simplifier.net/resolve?scope=ehealthplatform.be.r4.federalprofiles@1.2.2&amp;canonical=https://www.ehealth.fgov.be/standards/fhir/StructureDefinition/be-practitioner\">BePractitioner</a></p></div><p><b>identifier</b>: id: 18749704477 (OFFICIAL)</p><p><b>name</b>: Katherine Pulaski (OFFICIAL)</p><p><b>telecom</b>: <a href=\"mailto:katherine.pulaski@enterprisehospital.be\">katherine.pulaski@enterprisehospital.be</a>, ph: 022675198(WORK), fax: 022675209(WORK)</p><p><b>address</b>: Jupiterlaan 5, 1853 Grimbergen(HOME)</p></div>"
        },
        "identifier" : [
          {
            "use" : "official",
            "system" : "https://www.ehealth.fgov.be/standards/fhir/NamingSystem/nihdi",
            "value" : "18749704477"
          }
        ],
        "name" : [
          {
            "use" : "official",
            "family" : "Pulaski",
            "given" : [
              "Katherine"
            ],
            "suffix" : [
              "MD"
            ]
          }
        ],
        "telecom" : [
          {
            "system" : "email",
            "value" : "katherine.pulaski@enterprisehospital.be",
            "use" : "work"
          },
          {
            "system" : "phone",
            "value" : "022675198",
            "use" : "work"
          },
          {
            "system" : "fax",
            "value" : "022675209",
            "use" : "work"
          }
        ],
        "address" : [
          {
            "use" : "home",
            "text" : "Jupiterlaan 5, 1853 Grimbergen",
            "line" : [
              "Jupiterlaan 5"
            ],
            "city" : "Grimbergen",
            "postalCode" : "1853",
            "country" : "BE"
          }
        ]
      }
    }
  ]
}